• 19 April 2018

    Pharma Technology Focus – Issue 70

    In this issue: A toolkit to enhance the user experience for life sciences, the problem of unapproved antibiotics in India, a new taxonomy for traditional Chinese medicine, inside Canada’s Centre...

  • 17 April 2018

    Azeliragon: The third Alzheimer’s failure of 2018

    After the termination of Takeda’s pioglitazone and Merck & Co.’s verubecestat, vTv Therapeutic’s azeliragon is now the third pipeline drug to fail clinical trials for Alzheimer’s disease (AD) this year.